REG - Hikma Pharmaceutical - Director/PDMR Shareholding
RNS Number : 8929YHikma Pharmaceuticals Plc17 May 2021
Hikma Pharmaceuticals PLC - EIP B and EIP C Vesting
LONDON, 17 May 2021: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards which were granted on 17 May 2019 under the 2014 Executive Incentive Plan ("EIP") Element B and granted on 16 May 2018 under the 2014 EIP Element C. The Element B awards vested two years after grant and the Element C awards vested three years after grant.
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Mazen Darwazah
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mazen Darwazah
2
Reason for the notification
a)
Position/status
Executive Vice Chairman
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083
b)
Nature of the transaction
Shares acquired from the vesting of conditional awards on
16 May 2021 under the EIP Element C. All Shares were retained.c)
Price(s) and volume(s)
Price(s): £nil
Volume(s): 12,042
d)
Aggregated information
- Volume
- Price
Total
12,042
£0.00
£0.00
e)
Date of the transaction
17 May 2021
f)
Place of the transaction
London Stock Exchange (XLON)
Riad Mishlawi
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Riad Mishlawi
2
Reason for the notification
a)
Position/status
PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083
b)
Nature of the transaction
Shares acquired from the vesting of conditional awards on
16 May 2021 under the EIP Element C. All Shares were retained.c)
Price(s) and volume(s)
Price(s): £nil
Volume(s): 22,601
d)
Aggregated information
- Volume
- Price
- Total
22,601
£0.00
£0.00
e)
Date of the transaction
17 May 2021
f)
Place of the transaction
London Stock Exchange (XLON)
Majda Labadi
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Majda Labadi
2
Reason for the notification
a)
Position/status
PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083
b)
Nature of the transaction
Shares acquired from the vesting of conditional awards on
16 May 2021 under the EIP Element C. All Shares were retained.c)
Price(s) and volume(s)
Price(s): £nil
Volume(s): 15,855
d)
Aggregated information
- Volume
- Price
- Total
15,855
£0.00
£0.00
e)
Date of the transaction
17 May 2021
f)
Place of the transaction
London Stock Exchange (XLON)
Bassam Kanaan
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Bassam Kanaan
2
Reason for the notification
a)
Position/status
PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083
b)
Nature of the transaction
Shares acquired from the vesting of conditional awards on
16 May 2021 under the EIP Element C. All Shares were retained.c)
Price(s) and volume(s)
Price(s): £nil
Volume(s): 25,729
d)
Aggregated information
- Volume
- Price
- Total
25,729
£0.00
£0.00
e)
Date of the transaction
17 May 2021
f)
Place of the transaction
London Stock Exchange (XLON)
Khalid Nabilsi
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Khalid Nabilsi
2
Reason for the notification
a)
Position/status
PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083
b)
Nature of the transaction
Shares acquired from the vesting of conditional awards on
16 May 2021 under the EIP Element C. All Shares were retained.c)
Price(s) and volume(s)
Price(s): £nil
Volume(s): 23,062
d)
Aggregated information
- Volume
- Price
- Total
23,062
£0.00
£0.00
e)
Date of the transaction
17 May 2021
f)
Place of the transaction
London Stock Exchange (XLON)
Susan Ringdal
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Susan Ringdal
2
Reason for the notification
a)
Position/status
PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083
b)
Nature of the transaction
Shares acquired from the vesting of conditional awards on
16 May 2021 under the EIP Element C. Shares were sold to cover tax and the remainder were retained.c)
Price(s) and volume(s)
Price(s): £nil
Volume(s): 7,522
Price(s): £23.835
Volume(s): 6,735
d)
Aggregated information
- Volume
- Price
- Total
14,257
£23.835
£160,528.73p
e)
Date of the transaction
17 May 2021
f)
Place of the transaction
London Stock Exchange (XLON)
Hussein Arkhagha
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Hussein Arkhagha
2
Reason for the notification
a)
Position/status
PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083
b)
Nature of the transaction
Shares acquired from the vesting of conditional awards on
17 May 2021 under the EIP Element B. All Shares were retained.c)
Price(s) and volume(s)
Price(s): £nil
Volume(s): 11,246
d)
Aggregated information
- Volume
- Price
- Total
11,246
£0.00
£0.00
e)
Date of the transaction
17 May 2021
f)
Place of the transaction
London Stock Exchange (XLON)
Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 276017 May 2021
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHBSGDUUUBDGBR
Recent news on Hikma Pharmaceuticals
See all newsREG - Hikma Pharmaceutical - Block listing Interim Review
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Hikma completes Xellia acquisition
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Half-year Report
Announcement